According to a recent report from WebMD News, a recent study, which asserted both Xarelto and Pradaxa were superior to Warfarin, found that Xarelto poses a higher risk of serious internal bleeding disorders than its competitor, Pradaxa. The drugs at issue are part of a new class of anticoagulants known as New Oral Anticoagulants (NOACs). Xarelto, Pradaxa, Eliquis, and Savaysa are the four NOACs approved by the United States Food and Drug Administration (FDA).
The risk of increased internal bleeding disorders for patients taking Xarelto over patients taking Pradaxa was seen in patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Afib, is characterized by an irregular heartbeat not caused by a heart valve defect. If this sounds familiar to you even though you do not suffer from Afib, it might be because Saturday Night Live alumni actor Kevin Nealon appears in a commercial where he discusses his own struggles with Afib and how taking Xarelto has helped him to lead a normal life. Continue reading